The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
Voting is now open for the 2024 Company of the Year Awards
Serialization deadlines will shortly be upon us – but, rather than entering into a blind panic, consider the long term.
Eva has some bad news for Gene in the latest edition of "Trials of a Medicine Maker."
The Medicine Maker's James Strachan speaks with Paul Evans from Johnson Matthey.
Tony van Bijleveld
Sitting Down With… Tony van Bijleveld, BU Head of Softgels, Pharma Services Group, Thermo Fisher Scientific, the Netherlands.
Outsourcing partnerships aim to reduce costs and improve efficiencies, but don't overlook the human elements!
Sitting Down With... Cornell Stamoran, Vice President of Corporate Strategy, Catalent Pharma Solutions, USA.
What does your product demand guesstimate look like, and how can you be sure things won’t suddenly change?
The US and and EU deadlines are approaching, but is the industry ready for serialization?
Scaling up a bioprocess doesn’t need to be a headache - especially when there are firms out there that can lend a helping hand
When making advanced medicines, the cost of manufacture must be lower than reimbursement
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
What’s Happening with CAR T Therapies?
Pharma’s Portal to the Lab of the Future
The Sulforaphane Promise